SCHEMBL8700638

SCHEMBL8700638

CCOC(=O)C1c2ccccc2CC1c1cccs1

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HTT P42858 2/20 0.52
MAPT P10636 2/20 0.52
ALDH1A1 P00352 4/20 0.48
PKM P14618 1/20 0.46
ADORA2B P29275 3/20 0.45
KMT2A Q03164 3/20 0.45
BRD4 O60885 2/20 0.43
KDM4E B2RXH2 4/20 0.42
TSHR P16473 2/20 0.42
HSD17B10 Q99714 2/20 0.42
HPGD P15428 1/20 0.42
CYP1A2 P05177 1/20 0.42
CYP2C19 P33261 1/20 0.42
LMNA P02545 1/20 0.41
POLB P06746 1/20 0.41
AGTR1 P30556 1/20 0.41
MEN1 O00255 2/20 0.40
ADORA3 P0DMS8 1/20 0.40
NPSR1 Q6W5P4 1/20 0.40
MAPK1 P28482 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7422279 0.81 HTT (0.39) HTTMAPTALDH1A1KMT2ATSHR
SCHEMBL8407013 0.77 CYP2C19 (0.48) HTTMAPTALDH1A1KMT2AKDM4E
SCHEMBL8406870 0.77 CYP2C19 (0.48) HTTMAPTALDH1A1KMT2AKDM4E
SCHEMBL24650855 0.76 MAPT (0.41) HTTMAPTALDH1A1KMT2AKDM4E
SCHEMBL7214018 0.72 MEN1 (0.50) KMT2ABRD4POLBMEN1NPSR1
SCHEMBL9097432 0.71 HTT (0.43) HTTMAPTALDH1A1PKMADORA2B
SCHEMBL9095969 0.71 HTT (0.42) HTTMAPTALDH1A1PKMADORA2B
SCHEMBL8700636 0.71 PKM (0.42) HTTMAPTALDH1A1PKMADORA2B
SCHEMBL13159207 0.69 CYP2C19 (0.46) HTTALDH1A1KMT2AKDM4ETSHR
SCHEMBL9770005 0.69 MAPT (0.38) HTTMAPTPKMKDM4ETSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5789415-A Azacyclic-heterocyclic compounds as angiotension II receptor antagonists PFIZER INC. (US) 1998-08-04 US disclosed